
In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The world's richest businessman and Tesla CEO Elon Musk is once again embroiled in controversy. L
Along with interference in the coal business and government contracts, the beating of Mukhtar Ans
Last month, the news came that Yuzvendra Chahal and Dhanashree Verma have got divorced and both h
Wimbledon: Djokovic wins 32nd consecutive match at Wimbledon, unseeded Eubanks upsets Tsitsipas
Serbia's veteran tennis player Novak Djokovic has confirmed his place in the quarterfinals of the
These three states failing to deal with Corona, the teams sent from the center reported the flaws
The second wave of the Coronavirus has seen the situation worsening throughout the country. Every
'Conspiracy to weaken democracy', BJP cornered Rahul Gandhi over US aid; Know the truth
The BJP on Thursday said that US President Donald Trump's remarks on USAID funding to India confi
Amidst the Lok Sabha elections, there is political turmoil regarding inheritance tax (division of
Maharashtra: Muslim student wrote a post in support of Nupur Sharma, police arrested
The case of Nupur Sharma, suspended from BJP, does not seem to be cooling down. Now a Muslim yout
Vikram Hospitalized: South actor Vikram's health deteriorated, admitted to Chennai hospital
Ponniyin Selvan Vikram Hospitalized: The health of South cinema veteran Vikram has suddenly deter
Now only seven days are left for the World Cup to be held in India. 10 teams will participate in